Form 4 for TER Teradyne
Accepted 2026-04-09 12:08:13 ET · period of report 2026-04-08 · accession 0000904454-26-000229 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-09 12:08 | 2026-04-08 | TER | Mills Regan | Pres, Product Test | S - Sale | $342.17 | -16 | 11.4K | -0.1% | -$5,475 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-08 | S | D | 16 | $342.17 | 11,399.35 | D | — | — | (F1) Following an administrative correction to the number of shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units on April 1, 2026, as reported on a Form 4 filed on April 3, 2026, an additional 16 shares were sold on April 8, 2026 pursuant to a sales plan adopted by the Reporting Person on November 25, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. |